AbbVie (NYSE:ABBV) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of AbbVie (NYSE:ABBV – Free Report) from a buy rating to a strong-buy rating in a research note released on Monday morning. Several other analysts have also issued reports on ABBV. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $194.00 target price on shares of AbbVie in a research […]
